The interleukin-1 receptor family

Abstract The activity of each member of the IL-1 family of ligands is mediated by its own receptor. Each ligand binds specifically to the extracellular “ligand binding chain” containing three Ig-like regions. With the exception of the IL-1 and IL-36 receptor antagonists, a second chain, termed the “...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Seminars in immunology 2013-12, Vol.25 (6), p.394-407
Hauptverfasser: Boraschi, Diana, Tagliabue, Aldo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 407
container_issue 6
container_start_page 394
container_title Seminars in immunology
container_volume 25
creator Boraschi, Diana
Tagliabue, Aldo
description Abstract The activity of each member of the IL-1 family of ligands is mediated by its own receptor. Each ligand binds specifically to the extracellular “ligand binding chain” containing three Ig-like regions. With the exception of the IL-1 and IL-36 receptor antagonists, a second chain, termed the “accessory chain”, is recruited, forms a heterotrimetic complex with the ligand binding chain and the ligand, and signal transduction is initiated. Each ligand binding or accessory chain shares a common cytosolic segment termed the Toll–IL-1-receptor (TIR) domain. Another family of 13 receptors, termed Toll-like receptors (TLR), have extracellular leucine-rich repeat domains, which bind a broad spectrum of microbial products. All TLR share a nearly identical TIR domain with all members of the IL-1 receptor family. Hence signal transduction and the biological consequences of TLR ligands and IL-1 family ligands are often the same and both receptor families contribute to innate inflammation and host defense. The IL-1 family of receptors is comprised of ten distinct but related gene products. The receptors are indicated by the term IL-1 receptor (IL-1R) followed by a numeral, assigned chronologically by discovery, for example, IL-1R1, IL-1R2, IL-1R3, etc. The ligand binding chain for IL-1α and IL-1β is IL-1R1 and the accessory chain is IL-1R3. IL-1α, IL-1β, IL-33 and IL-36 use IL-1R3 as their accessory chain. IL-1R2 is a non-signalling “decoy” receptor that sequesters the IL-1β and IL-1R3. IL-1R8 exhibits anti-inflammatory properties by reducing IL-1 and TLR signalling. Presently there are two orphan receptors, IL-1R9 and IL-1R10, which have no known function. This review examines the characteristics and functional roles of the IL-1R family in the regulation of innate inflammation, host defense and acquired immunity.
doi_str_mv 10.1016/j.smim.2013.10.023
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1492716826</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1044532313001152</els_id><sourcerecordid>1492716826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-ec00fe5758b77eb36de851966c40494399326352b76f70b4d8ef8944df98ce53</originalsourceid><addsrcrecordid>eNp9kc1LxDAQxYMo7rr6D3iQ9ealayZJ0wZEkMUvWPDg3kObTjHdfqxJK-x_b8quHjx4mmF478H8HiGXQBdAQd5WC9_YZsEo8HBYUMaPyBSokhGXkB6PuxBRzBmfkDPvK0opFymckgkTTEjGkim5Xn_g3LY9uhqHjW0jmDs0uO07Ny-zxta7c3JSZrXHi8OckfXT43r5Eq3enl-XD6vICIA-QkNpiXESp3mSYM5lgWkMSkojqFCCK8WZ5DHLE1kmNBdFimWqhChKlRqM-Yzc7GO3rvsc0Pe6sd5gXWctdoPXIBRLQKYhZEbYXmpc573DUm-dbTK300D1SEZXeiSjRzLjLZAJpqtD_pA3WPxaflAEwd1egOHJL4tOe2OxNVjYQKTXRWf_z7__Yze1ba3J6g3u0Ffd4NqAT4P2TFP9PnYzVgOcUoCY8W9LBYbA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1492716826</pqid></control><display><type>article</type><title>The interleukin-1 receptor family</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Boraschi, Diana ; Tagliabue, Aldo</creator><creatorcontrib>Boraschi, Diana ; Tagliabue, Aldo</creatorcontrib><description>Abstract The activity of each member of the IL-1 family of ligands is mediated by its own receptor. Each ligand binds specifically to the extracellular “ligand binding chain” containing three Ig-like regions. With the exception of the IL-1 and IL-36 receptor antagonists, a second chain, termed the “accessory chain”, is recruited, forms a heterotrimetic complex with the ligand binding chain and the ligand, and signal transduction is initiated. Each ligand binding or accessory chain shares a common cytosolic segment termed the Toll–IL-1-receptor (TIR) domain. Another family of 13 receptors, termed Toll-like receptors (TLR), have extracellular leucine-rich repeat domains, which bind a broad spectrum of microbial products. All TLR share a nearly identical TIR domain with all members of the IL-1 receptor family. Hence signal transduction and the biological consequences of TLR ligands and IL-1 family ligands are often the same and both receptor families contribute to innate inflammation and host defense. The IL-1 family of receptors is comprised of ten distinct but related gene products. The receptors are indicated by the term IL-1 receptor (IL-1R) followed by a numeral, assigned chronologically by discovery, for example, IL-1R1, IL-1R2, IL-1R3, etc. The ligand binding chain for IL-1α and IL-1β is IL-1R1 and the accessory chain is IL-1R3. IL-1α, IL-1β, IL-33 and IL-36 use IL-1R3 as their accessory chain. IL-1R2 is a non-signalling “decoy” receptor that sequesters the IL-1β and IL-1R3. IL-1R8 exhibits anti-inflammatory properties by reducing IL-1 and TLR signalling. Presently there are two orphan receptors, IL-1R9 and IL-1R10, which have no known function. This review examines the characteristics and functional roles of the IL-1R family in the regulation of innate inflammation, host defense and acquired immunity.</description><identifier>ISSN: 1044-5323</identifier><identifier>EISSN: 1096-3618</identifier><identifier>DOI: 10.1016/j.smim.2013.10.023</identifier><identifier>PMID: 24246227</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adaptive Immunity ; Allergy and Immunology ; Humans ; IL-1 receptors ; IL-1R family ; Inflammation ; Inflammation - immunology ; Interleukin-1 ; Interleukin-1 - immunology ; Receptors, Interleukin-1 - genetics ; Receptors, Interleukin-1 - immunology ; Receptors, Interleukin-1 - ultrastructure ; Resolution ; Signal Transduction - immunology ; Toll-Like Receptors - genetics ; Toll-Like Receptors - immunology</subject><ispartof>Seminars in immunology, 2013-12, Vol.25 (6), p.394-407</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-ec00fe5758b77eb36de851966c40494399326352b76f70b4d8ef8944df98ce53</citedby><cites>FETCH-LOGICAL-c411t-ec00fe5758b77eb36de851966c40494399326352b76f70b4d8ef8944df98ce53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.smim.2013.10.023$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24246227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boraschi, Diana</creatorcontrib><creatorcontrib>Tagliabue, Aldo</creatorcontrib><title>The interleukin-1 receptor family</title><title>Seminars in immunology</title><addtitle>Semin Immunol</addtitle><description>Abstract The activity of each member of the IL-1 family of ligands is mediated by its own receptor. Each ligand binds specifically to the extracellular “ligand binding chain” containing three Ig-like regions. With the exception of the IL-1 and IL-36 receptor antagonists, a second chain, termed the “accessory chain”, is recruited, forms a heterotrimetic complex with the ligand binding chain and the ligand, and signal transduction is initiated. Each ligand binding or accessory chain shares a common cytosolic segment termed the Toll–IL-1-receptor (TIR) domain. Another family of 13 receptors, termed Toll-like receptors (TLR), have extracellular leucine-rich repeat domains, which bind a broad spectrum of microbial products. All TLR share a nearly identical TIR domain with all members of the IL-1 receptor family. Hence signal transduction and the biological consequences of TLR ligands and IL-1 family ligands are often the same and both receptor families contribute to innate inflammation and host defense. The IL-1 family of receptors is comprised of ten distinct but related gene products. The receptors are indicated by the term IL-1 receptor (IL-1R) followed by a numeral, assigned chronologically by discovery, for example, IL-1R1, IL-1R2, IL-1R3, etc. The ligand binding chain for IL-1α and IL-1β is IL-1R1 and the accessory chain is IL-1R3. IL-1α, IL-1β, IL-33 and IL-36 use IL-1R3 as their accessory chain. IL-1R2 is a non-signalling “decoy” receptor that sequesters the IL-1β and IL-1R3. IL-1R8 exhibits anti-inflammatory properties by reducing IL-1 and TLR signalling. Presently there are two orphan receptors, IL-1R9 and IL-1R10, which have no known function. This review examines the characteristics and functional roles of the IL-1R family in the regulation of innate inflammation, host defense and acquired immunity.</description><subject>Adaptive Immunity</subject><subject>Allergy and Immunology</subject><subject>Humans</subject><subject>IL-1 receptors</subject><subject>IL-1R family</subject><subject>Inflammation</subject><subject>Inflammation - immunology</subject><subject>Interleukin-1</subject><subject>Interleukin-1 - immunology</subject><subject>Receptors, Interleukin-1 - genetics</subject><subject>Receptors, Interleukin-1 - immunology</subject><subject>Receptors, Interleukin-1 - ultrastructure</subject><subject>Resolution</subject><subject>Signal Transduction - immunology</subject><subject>Toll-Like Receptors - genetics</subject><subject>Toll-Like Receptors - immunology</subject><issn>1044-5323</issn><issn>1096-3618</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1LxDAQxYMo7rr6D3iQ9ealayZJ0wZEkMUvWPDg3kObTjHdfqxJK-x_b8quHjx4mmF478H8HiGXQBdAQd5WC9_YZsEo8HBYUMaPyBSokhGXkB6PuxBRzBmfkDPvK0opFymckgkTTEjGkim5Xn_g3LY9uhqHjW0jmDs0uO07Ny-zxta7c3JSZrXHi8OckfXT43r5Eq3enl-XD6vICIA-QkNpiXESp3mSYM5lgWkMSkojqFCCK8WZ5DHLE1kmNBdFimWqhChKlRqM-Yzc7GO3rvsc0Pe6sd5gXWctdoPXIBRLQKYhZEbYXmpc573DUm-dbTK300D1SEZXeiSjRzLjLZAJpqtD_pA3WPxaflAEwd1egOHJL4tOe2OxNVjYQKTXRWf_z7__Yze1ba3J6g3u0Ffd4NqAT4P2TFP9PnYzVgOcUoCY8W9LBYbA</recordid><startdate>20131215</startdate><enddate>20131215</enddate><creator>Boraschi, Diana</creator><creator>Tagliabue, Aldo</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131215</creationdate><title>The interleukin-1 receptor family</title><author>Boraschi, Diana ; Tagliabue, Aldo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-ec00fe5758b77eb36de851966c40494399326352b76f70b4d8ef8944df98ce53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adaptive Immunity</topic><topic>Allergy and Immunology</topic><topic>Humans</topic><topic>IL-1 receptors</topic><topic>IL-1R family</topic><topic>Inflammation</topic><topic>Inflammation - immunology</topic><topic>Interleukin-1</topic><topic>Interleukin-1 - immunology</topic><topic>Receptors, Interleukin-1 - genetics</topic><topic>Receptors, Interleukin-1 - immunology</topic><topic>Receptors, Interleukin-1 - ultrastructure</topic><topic>Resolution</topic><topic>Signal Transduction - immunology</topic><topic>Toll-Like Receptors - genetics</topic><topic>Toll-Like Receptors - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boraschi, Diana</creatorcontrib><creatorcontrib>Tagliabue, Aldo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boraschi, Diana</au><au>Tagliabue, Aldo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The interleukin-1 receptor family</atitle><jtitle>Seminars in immunology</jtitle><addtitle>Semin Immunol</addtitle><date>2013-12-15</date><risdate>2013</risdate><volume>25</volume><issue>6</issue><spage>394</spage><epage>407</epage><pages>394-407</pages><issn>1044-5323</issn><eissn>1096-3618</eissn><abstract>Abstract The activity of each member of the IL-1 family of ligands is mediated by its own receptor. Each ligand binds specifically to the extracellular “ligand binding chain” containing three Ig-like regions. With the exception of the IL-1 and IL-36 receptor antagonists, a second chain, termed the “accessory chain”, is recruited, forms a heterotrimetic complex with the ligand binding chain and the ligand, and signal transduction is initiated. Each ligand binding or accessory chain shares a common cytosolic segment termed the Toll–IL-1-receptor (TIR) domain. Another family of 13 receptors, termed Toll-like receptors (TLR), have extracellular leucine-rich repeat domains, which bind a broad spectrum of microbial products. All TLR share a nearly identical TIR domain with all members of the IL-1 receptor family. Hence signal transduction and the biological consequences of TLR ligands and IL-1 family ligands are often the same and both receptor families contribute to innate inflammation and host defense. The IL-1 family of receptors is comprised of ten distinct but related gene products. The receptors are indicated by the term IL-1 receptor (IL-1R) followed by a numeral, assigned chronologically by discovery, for example, IL-1R1, IL-1R2, IL-1R3, etc. The ligand binding chain for IL-1α and IL-1β is IL-1R1 and the accessory chain is IL-1R3. IL-1α, IL-1β, IL-33 and IL-36 use IL-1R3 as their accessory chain. IL-1R2 is a non-signalling “decoy” receptor that sequesters the IL-1β and IL-1R3. IL-1R8 exhibits anti-inflammatory properties by reducing IL-1 and TLR signalling. Presently there are two orphan receptors, IL-1R9 and IL-1R10, which have no known function. This review examines the characteristics and functional roles of the IL-1R family in the regulation of innate inflammation, host defense and acquired immunity.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24246227</pmid><doi>10.1016/j.smim.2013.10.023</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1044-5323
ispartof Seminars in immunology, 2013-12, Vol.25 (6), p.394-407
issn 1044-5323
1096-3618
language eng
recordid cdi_proquest_miscellaneous_1492716826
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adaptive Immunity
Allergy and Immunology
Humans
IL-1 receptors
IL-1R family
Inflammation
Inflammation - immunology
Interleukin-1
Interleukin-1 - immunology
Receptors, Interleukin-1 - genetics
Receptors, Interleukin-1 - immunology
Receptors, Interleukin-1 - ultrastructure
Resolution
Signal Transduction - immunology
Toll-Like Receptors - genetics
Toll-Like Receptors - immunology
title The interleukin-1 receptor family
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A08%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20interleukin-1%20receptor%20family&rft.jtitle=Seminars%20in%20immunology&rft.au=Boraschi,%20Diana&rft.date=2013-12-15&rft.volume=25&rft.issue=6&rft.spage=394&rft.epage=407&rft.pages=394-407&rft.issn=1044-5323&rft.eissn=1096-3618&rft_id=info:doi/10.1016/j.smim.2013.10.023&rft_dat=%3Cproquest_cross%3E1492716826%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1492716826&rft_id=info:pmid/24246227&rft_els_id=S1044532313001152&rfr_iscdi=true